FLT190

GENETIC2 trials

Sponsors

Spur Therapeutics

Conditions

Fabry DiseaseLysosomal Storage Diseases

Phase 1

A Fabry Disease Gene Therapy Study

TerminatedNCT04040049

Spur TherapeuticsFabry Disease, Lysosomal Storage Diseases

Start: 2019-07-08End: 2023-05-02Updated: 2026-09-03

A Long Term Follow-Up Study of Fabry Disease Subjects Treated With FLT190

TerminatedNCT04455230

Spur TherapeuticsFabry Disease, Lysosomal Storage Diseases

Start: 2020-09-08End: 2023-09-28Updated: 2026-09-03

Related Papers

Preclinical evaluation of FLT190, a liver-directed AAV gene therapy for Fabry disease

Gene Therapy2023-01-1136 citations